Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 9,660 shares at $233.31 ($2.2M) on 2023-02-03, disclosed to the SEC on 2023-02-03.
Open-market sale of $2.2M ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $223.97 | 73 | $16K | 0.7% |
| 2 | $225.80 | 963 | $217K | 9.8% |
| 3 | $225.80 | 963 | $217K | 9.8% |
| 4 | $226.62 | 561 | $127K | 5.7% |
| 5 | $226.62 | 561 | $127K | 5.7% |
| 6 | $227.38 | 4 |
| $910 |
| 0.0% |
| 7 | $227.68 | 128 | $29K | 1.3% |
| 8 | $230.20 | 185 | $43K | 1.9% |
| 9 | $231.35 | 865 | $200K | 9.0% |
| 10 | $231.35 | 865 | $200K | 9.0% |
| 11 | $232.53 | 1,293 | $301K | 13.5% |
| 12 | $232.53 | 1,293 | $301K | 13.5% |
| 13 | $233.31 | 953 | $222K | 10.0% |
| 14 | $233.31 | 953 | $222K | 10.0% |
| Total | $230.27 avg | 9,660 | $2.2M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $607K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |